RBC Europe’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-231
Closed -$5.8K 1173
2020
Q3
$5.8K Hold
231
﹤0.01% 889
2020
Q2
$1.76K Hold
231
﹤0.01% 963
2020
Q1
$2.11K Hold
231
﹤0.01% 911
2019
Q4
$1.19K Hold
231
﹤0.01% 984
2019
Q3
$1.34K Hold
231
﹤0.01% 981
2019
Q2
$739 Hold
231
﹤0.01% 1019
2019
Q1
$947 Hold
231
﹤0.01% 1024
2018
Q4
$1.46K Hold
231
﹤0.01% 1012
2018
Q3
$3.82K Hold
231
﹤0.01% 985
2018
Q2
$3.86K Hold
231
﹤0.01% 1000
2018
Q1
$3.59K Hold
231
﹤0.01% 1001
2017
Q4
$4.36K Hold
231
﹤0.01% 979
2017
Q3
$6.75K Buy
+231
New +$6.82K ﹤0.01% 908

Other funds holding ACH

RBC Europe's ACH Position: Q4 2020 in Review

RBC Europe sold out of Accendra Health (ACH) in Q4 2020, closing a stake of 231 shares — an estimated $5.8K sold.

RBC Europe first reported a position in ACH in Q3 2017 and held it in 13 quarters. The position peaked at $6.75K in Q3 2017. 232 funds tracked by Wall St. Rank hold ACH as of Q4 2020.

  • RBC Europe reported no remaining Accendra Health position as of Q4 2020 after selling out during the quarter.
  • RBC Europe sold 231 Accendra Health shares in Q4 2020, an estimated $5.8K.
  • RBC Europe first reported a position in Accendra Health in Q3 2017 and held it in 13 quarters.
  • RBC Europe's Accendra Health position peaked at $6.75K in Q3 2017.
  • 232 funds tracked by Wall St. Rank held Accendra Health as of Q4 2020.

Based on RBC Europe's 13F filing for Q4 2020, filed 9 Nov 2023.